Stock Comparison

REGN vs VRDN

Regeneron Pharmaceuticals Inc and Viridian Therapeutics Inc side by side — valuation, profitability, growth and risk.

REGN

Regeneron Pharmaceuticals Inc

Healthcare

VRDN

Viridian Therapeutics Inc

Healthcare

Valuation

Market Cap

$80.55B

$2.55B

P/E (TTM)

19.4

—

Forward P/E

17.1

1.0

Price/Sales

5.2

35.8

Price/Book

2.5

4.5

EV/EBITDA

13.1

-3.0

Dividend Yield

0.45%

—

Profitability

Net Margin

29.65%

-508.46%

Operating Margin

24.32%

-543.86%

Return on Equity

14.00%

-65.70%

Return on Assets

6.53%

-30.20%

Growth (YoY)

Revenue Growth

16.70%

278.70%

Earnings Growth

-4.50%

0.00%

Price & Risk

Beta

0.2

0.9

52-Week High

$810.12

$33.78

52-Week Low

$553.38

$13.30

Analyst Target

$833.54

$36.62

Compare REGN and VRDN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.